drugset / Trial / NCT00419471

Escitalopram in Depressive Patients With Acute Coronary Artery Syndrome

NCT00419471

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aimed to evaluate the efficacy and safety of escitalopram in the treatment of depressive patients with acute coronary artery syndrome (CAS).

Timeline

Start
2007-05
Primary completion
2013-03
Completion
2013-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 5 mg Oral
Subject Escitalopram Small molecule 10 mg Oral
Subject Escitalopram Small molecule 15 mg Oral
Subject Escitalopram Small molecule 20 mg Oral